← Leaderboards
Paul B Myrdal
University Of Arizona
$989,475
Attributed
$989,475
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $190.4K · FY2005–15$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$989,475 · 2
By mechanism
P01$838,892 · 1
R03$150,583 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- David S Alberts$22,074,619
- Timothy Bowden$2,089,276
- Steven P Stratton$2,491,979
- Clara Curiel-Lewandrowski$4,151,872
- Janine G Einspahr$5,319,232
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationEpidermisEfficacy EvaluationEnsureBiometryAbsorptionBasic ScienceCarcinogenesisEngineeringChemical StabilityChemopreventionChemopreventive AgentClinical DistributionClinical ResearchClinical TrialsConsultationsDecision TreesDesignAnalogDrug CandidateDrug DevelopmentDrug FormulationsDrug KineticsInvestigational New Drug Application
Grant awards (9)
Drug Development$173,427
P01 · FY2015 · CA · contact PI
Drug Development$158,940
P01 · FY2014 · CA · contact PI
Drug Development$164,138
P01 · FY2013 · CA · contact PI
Drug Development$175,209
P01 · FY2012 · CA · contact PI
Drug Development$8,485
P01 · FY2012 · CA · contact PI
Drug Development$6,673
P01 · FY2012 · CA · contact PI
Drug Development$152,020
P01 · FY2011 · CA · contact PI
Elucidation of the Lipoxygenase-Mediated Pathway of Lun*$75,250
R03 · FY2005 · CA
Lipoxygenase-Mediated Pathway of Lung Tumor Progression$75,333
R03 · FY2004 · CA